Skip to main content
Clinical Trials/NCT01656317
NCT01656317CompletedNot Applicable

Effect of Early Rehabilitation in Patients With Acute Subarachnoid Hemorrhage

Oslo University Hospital2 sites in 1 country171 target enrollmentStarted: January 1, 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
171
Locations
2
Primary Endpoint
Glasgow Coma Scale (GCS)

Study Overview

Brief Summary

The study's main objective will be to assess which effect early initiated rehabilitation has on the frequency of complications and the level of physical and cognitive functioning after aneurysmal subarachnoid hemorrhage (SAH).

To this end the following aspects will be investigated:

The frequency of complications (with special emphasis on pulmonary complications,thromboembolic events, cerebral vasospasm, unintended discontinuation of drains and lines)

  • Length of stay in hospitals and socio-economic impact
  • Physical and cognitive function in the early and chronic phase after SAH
  • Health-related quality of life and participation in society in the chronic phase

Detailed Description

Oslo University Hospital (OUS) is the primary hospital for Health Region South-East regarding treatment of patients with SAH. Approximately 120 patients are referred annually. OUS,Rikshospitalet, Dept of Neurosurgery offers 24/7 service of surgical and vascular aneurysm repair performed by a dedicated vascular team.

Patients admitted in 2012 are treated in accordance to the standard institutional protocol plus an early rehabilitation model adapted to SAH, while patients admitted in 2011 who did not receive any early rehabilitation, but apart from that were treated identically, serve as a control group.

All patients admitted to the intermediate unit at OUS in 2011 and 2012 with aneurysmal SAH and repaired aneurysm will be invited to participate in this study. Examination of the patients from both 2011 and 2012 will be performed as part of routine, neurosurgical follow- up which is in the early phase at 3-6 months and in the chronic phase at least 12 months post SAH. Exclusion criteria for participation in the study: unsecured ruptured aneurysm, symptomatic aneurysm without rupture, previous SAH or brain injury, diagnosis of a neurodegenerative disorder, patients from other health regions or tourists, patients that were treated at the intensive care unit (ICU )only.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All patients admitted to the intermediate unit at OUS in 2011 and 2012 with aneurysmal SAH and repaired aneurysm will be invited to participate in this study.

Exclusion Criteria

  • Unsecured ruptured aneurysm,
  • Symptomatic aneurysm without rupture
  • Previous SAH or brain injury, diagnosis of a neurodegenerative disorder
  • Patients from other health regions or tourists
  • Patients that were treated at the intensive care unit (ICU )only.

Outcomes

Primary Outcomes

Glasgow Coma Scale (GCS)

Time Frame: up to 10 weeks

Secondary Outcomes

  • Disability Rating Scale (DRS)(3-6 and 12 months after SAH)
  • High Level Mobility Assessment Tool (HIMAT)(3-6 and 12 months after SAH)
  • Glasgow Outcome Scale Extended (GOSE)(3-6 months and 12 months after SAH)
  • Functional Independence Measure (FIM)(3-6 months and 12 months after SAH)
  • Coma Recovery Scale (CRS)(3-6 and 12 months after SAH)

Investigators

Sponsor
Oslo University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tanja Karic

medical doctor

Oslo University Hospital

Study Sites (2)

Loading locations...

Similar Trials